Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sofinnova Investments, Inc.
Form 13F · Q2 2026

Sofinnova Investments, Inc.

CIK 1631134Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.9B
Reported book value
57
Positions
12
Quarters on record
Top 50
Positions

Sofinnova Investments, Inc. — holdings

Top 50 positions of 57, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1NTRA Natera Inc1.6M+0.0%$421M21.8%
2VERA Vera Therapeutics Inc2.8M+0.0%$120M6.2%
3GMAB Genmab A/S4.0M+437.7%$111M5.7%
4JAZZ Jazz Pharmaceuticals Plc365,341−38.9%$88M4.6%
5RAPP Rapport Therapeutics Inc1.9M+0.0%$79M4.1%
6SPTX Seaport Therapeutics Inc3.6M—$77M4.0%
7AVBP Arrivent Biopharma Inc1.7M+0.0%$59M3.0%
8RARE Ultragenyx Pharmaceutical In1.7M−45.4%$57M3.0%
9BIOA Bioage Labs Inc2.3M+0.0%$56M2.9%
10BMY Bristol-Myers Squibb Co876,970−55.9%$51M2.6%
11SUPN Supernus Pharmaceuticals1.0M+8.6%$48M2.5%
12RYTM Rhythm Pharmaceuticals Inc408,027−9.3%$45M2.3%
13GILD Gilead Sciences Inc343,100—$43M2.2%
14UTHR United Therapeutics Corp Del76,489−52.2%$41M2.1%
15COGT Cogent Biosciences Inc1.0M−51.0%$40M2.1%
16AXSM Axsome Therapeutics Inc.160,429−24.6%$39M2.0%
17IMTX Immatics N.V3.7M+1.1%$37M1.9%
18DYN Dyne Therapeutics Inc1.7M+1.5%$37M1.9%
19IMNM Immunome Inc1.7M+1.1%$36M1.9%
20IDYA Ideaya Biosciences Inc925,119−18.3%$34M1.8%
21ANAB Anaptysbio Inc493,536+98.8%$33M1.7%
22NKTR Nektar Therapeutics471,763−7.4%$33M1.7%
23PHVS Pharvaris N V881,299+7.7%$30M1.6%
24RCUS Arcus Biosciences Inc945,690+2.4%$29M1.5%
25INBX Inhibrx Biosciences Inc303,103−25.3%$29M1.5%
26BMRN Biomarin Pharmaceutical Inc358,568−54.1%$21M1.1%
27MANE Veradermics Inc148,993+103.2%$18M0.9%
28ALC Alcon Ag255,824−65.0%$17M0.9%
29INSM Insmed Inc158,398−54.2%$17M0.9%
30EWTX Edgewise Therapeutics Inc380,923−1.4%$15M0.8%
31NRIX Nurix Therapeutics Inc524,098—$13M0.7%
32DSGN Design Therapeutics Inc865,135—$13M0.6%
33DFTX Definium Therapeutics Inc255,903−25.6%$12M0.6%
34TRAX First Tracks Biotherapeutics565,199—$11M0.6%
35ABT Abbott Laboratories122,998—$11M0.6%
36IRON Disc Medicine Inc146,239+86.7%$11M0.6%
37TENX Tenax Therapeutics Inc500,039+379.0%$7M0.4%
38SION Sionna Therapeutics Inc144,432—$6M0.3%
39ABSI Absci Corporation337,400—$4M0.2%
40MIRM Mirum Pharmaceuticals Inc27,591+0.0%$3M0.2%
41JBIO Jade Biosciences Inc107,391+0.0%$2M0.1%
42SVRA Savara Inc364,763+0.0%$2M0.1%
43PRAX Praxis Precision Medicines I6,440−89.9%$2M0.1%
44SEPN Septerna Inc47,506+0.0%$2M0.1%
45OKUR Onkure Therapeutics Inc321,692+127.0%$1M0.1%
46SGMT Sagimet Biosciences Inc166,667—$1M0.1%
47WVE Wave Life Sciences Ltd189,253+0.0%$1M0.1%
48AKTS Aktis Oncology Inc32,436—$1M0.1%
49TYRA Tyra Biosciences Inc32,267−84.2%$1M0.1%
50BOLT Bolt Biotherapeutics Inc137,721+0.0%$530,2260.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.